Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 12, 2020

SELL
$11.11 - $24.72 $2.12 Million - $4.71 Million
-190,483 Closed
0 $0
Q4 2019

Feb 18, 2020

SELL
$12.94 - $20.58 $1.72 Million - $2.74 Million
-132,917 Reduced 41.1%
190,483 $2.82 Million
Q1 2019

May 10, 2019

BUY
$9.47 - $17.01 $3.06 Million - $5.5 Million
323,400 New
323,400 $3.06 Million

Others Institutions Holding HARP

About Harpoon Therapeutics, Inc.


  • Ticker HARP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,106,800
  • Description
  • Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...
More about HARP
Track This Portfolio

Track Fosun International LTD Portfolio

Follow Fosun International LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fosun International LTD with notifications on news.